Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
CRISPR, the disruptor : Nature News & Comment
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
Untangling the CRISPR cancer scare
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
CRISPR-Cas 9 corrects genetic defects in mice
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
Focus on CRISPR tools and therapies | Nature Biotechnology
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
CRISPR: gene editing is just the beginning : Nature News & Comment
PDF) The CRISPR tool kit for genome editing and beyond
The kill-switch for CRISPR that could make gene-editing safer
